Benlor 5mg

Tablet
Desloratadine
BENHAM pharmaceuticals

Other Strength:

Alternative:
- Momento 5mg
- ORINEX 5mg
- Neocilor 5mg
- Deslorin 5mg
- Destin 5mg
- Aloran 5mg
- Desolet 5mg
- Sedno 5mg



Benlor
Presentation:
Benlor Tablet: Each film-coated tablet contains Desloratadine INN 5 mg.
Descriptions:
Benlor is a preparation of Desloratadine. Desloratadine is a long-acting tricyclic histamine antagonist with selective H1-receptor antagonist activity. It is a non-sedating antihistamine. Desloratadine has effects on the chronic inflammatory response to allergens and lacks effects on the QT interval of ECG, unlike some other non-sedating antihistamines.

Indication:
Allergic rhinitis:
Benlor is indicated for the relief of nasal and non-nasal symptoms of allergic rhinitis (seasonal and perennial).

Chronic idiopathic urticaria:
Benlor is indicated for the symptomatic relief of pruritus, reduction in the number of hives and size of hives, in patients with chronic idiopathic urticaria.

Dosage & Administration:
As there are no food effects on the bioavailability, Benlor may be taken without regard to meal.

Adults and adolescent of 12 years or over: 5 mg. once daily.
Child 6-11 years: 2.5 mg. once daily.
Child 12 months -5 years: 1.25 mg. (2.5 ml Benlor syrup) once daily.
Child 6 months-11 months: 1 mg. (2 ml Benlor syrup) once daily.
Patients with liver or renal impairment:
A starting dose of one Benlor tablet (Desloratadine 5 mg.) every other day is recommended.

pediatric use:
The safety and effectiveness of Desloratadine in pediatric patients under 6 months of age has not been established.

Side Effects:
Desloratadine is generally well tolerated. However, dry mouth, fatigue, somnolence and myalgia are commonly reported side-effects. Less common Side-effects may include dizziness, headache and nausea. Rarely rash, pruritus and urticaria may occur.

Contraindications:
Benlor is contraindicated in patients who are hypersansitive to this medication or to any of its ingredients or to Loratadine.

Use in pregnancy & Lactation:
Pregnancy:
There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Desloratadine should be used in pregnancy only if clearly needed.

Lactation:
Desloratadine passes into breast milk. Therefore, a decision should be made whether to discontinue nursing or to discontinue Desloratadine, taking into account the importance of the drug to the mother.

Drug interaction:
No clinically important drug interactions have been reported.

Overdose:
No clinically relevant adverse effect have been reported in case of overdosage. However, in the event of overdosage, symptomatic and supportive treatment is recommended.

এই পাতাটি ২৮৬ বার দেখা হয়েছে